OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
28/04/2022 - 3 minutes
GPCR
Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
07/05/2019 - 3 minutes
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology…
05/10/2017 - 2 minutes
Meet the Young CEO of a PCR Workflow Automation Company
He is a young entrepreneur with a fast growing company. His software for the automation…
02/10/2017 - 7 minutes
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein…
26/09/2017 - 2 minutes
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…
01/09/2017 - 2 minutes
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
17/07/2017 - 6 minutes
MorphoSys’ First Lanthipeptide Completes Phase I Successfully
UPDATE (19/05/2017): MorphoSys has announced the completion of the Phase I study with MOR107, which…
19/05/2017 - 2 minutes
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be…
18/05/2017 - 1 minute
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
Heptares Therapeutics has published the detailed structure and mechanism of action of a difficult-to-target GPCR…
27/04/2017 - 2 minutes
Young Belgian Biotech will tackle Fibrosis with a New Grant
Confo Therapeutics has received a €1.6M grant to support the discovery of drugs against fibrosis,…
01/02/2017 - 2 minutes
New British Biotech-Academia Alliance takes on Cardiovascular Disease
Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for…
31/01/2017 - 2 minutes
